CRON Stock Forecast: Cronos Signs $122-Million Deal to Produce Lab-Grown Cannabis
September 05, 2018 at 09:30 AM EDT
iStock.com/PhotoBylove CRON Stock Forecast Cronos Group Inc (NASDAQ:CRON) is looking to take pot out of the ground and into the lab, signing a $122.0-million deal with Ginkgo Bioworks Inc. to genetically engineer the active compounds found [...]
